Qualitative assessment of the clinical meaningfulness of MDS-UPDRS part III items in early-stage Parkinson's
{{output}}
IntroductionDevelopers of disease-modifying therapies (DMTs) for early-stage Parkinson's are in dialogue with regulators to identify the relative merits of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) for detecting cli... ...
